U.S. tissue bank strikes deal for cell removal technology

06/18/2013 | Bloomberg

Community Tissue Services of Dayton, Ohio, will use U.K.-based Tissue Regenix's cell-removal technology to produce decellularized skin, which either company may then distribute in the U.S. The tissue will be used for wound care and burn products, among other uses. The technology allows Tissue Regenix to remove cells from animal tissue, creating a matrix for the patient's own cells to grow without rejecting the tissue.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC